​
​

Eagle Pharmaceuticals Ownership | Who Owns Eagle Pharmaceuticals?

OverviewChart

Eagle Pharmaceuticals Ownership Summary

Eagle Pharmaceuticals is owned by 75.40% institutional investors, 12.02% insiders, and 12.58% retail investors. Aigh capital management is the largest institutional shareholder, holding 9.25% of EGRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.84% of its assets in Eagle Pharmaceuticals shares.

EGRX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockEagle Pharmaceuticals75.40%12.02%12.58%
SectorHealthcare Stocks 47.38%7.99%44.63%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.80%9.10%56.10%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Aigh capital management1.21M9.25%$6.78M
Citigroup1.00M7.65%$5.61M
Nantahala capital management1.00M7.64%$5.60M
Aqr capital management696.80K5.32%$3.90M
Vanguard group564.40K4.31%$3.16M
Blackrock352.76K2.69%$1.98M
Bank of america corp /de/325.52K2.49%$1.82M
Morgan stanley300.45K2.30%$1.68M
Renaissance244.25K1.87%$1.37M
Two sigma advisers, lp224.82K1.72%$1.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Aigh capital management1.21M2.11%$6.78M
Nantahala capital management1.00M0.33%$5.60M
Ajovista11.23K0.18%$62.90K
Tang capital management118.86K0.07%$665.60K
Rbf capital128.09K0.04%$717.29K
J. goldman & co lp191.11K0.03%$1.07M
Wealthcollab4.38K0.02%$24.50K
Pdt partners30.01K0.02%$168.06K
Point72 asia (singapore) pte.11.61K0.01%$65.03K
Xtx topco20.20K0.01%$113.14K

Top Buyers

HolderShares% AssetsChange
Nantahala capital management1.00M0.33%1.00M
Citigroup1.00M0.00%998.84K
Rbf capital128.09K0.04%128.09K
Cubist systematic strategies25.81K0.00%25.81K
Aigh capital management1.21M2.11%25.00K

Top Sellers

HolderShares% AssetsChange
Blackrock352.76K--545.04K
Lsv asset management---295.39K
Aqr capital management696.80K0.01%-182.28K
State street35.82K--177.85K
Perceptive advisors---173.37K

New Positions

HolderShares% AssetsChangeValue
Nantahala capital management1.00M0.33%1.00M$5.60M
Rbf capital128.09K0.04%128.09K$717.29K
Vanguard personalized indexing management13.63K0.00%13.63K$76.32K
Mackenzie financial10.79K0.00%10.79K$60.40K
Macquarie group518.00-518.00$2.90K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
New york state common retirement fund-90.00
Nordwand advisors-100.00
Barrett & company-100.00
Fortitude family office-117.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202476-18.28%9,870,425-5.60%751.18%24-41.46%4216.67%
Mar 31, 202493-12.26%10,455,7704.33%791.36%41-36.92%3650.00%
Dec 31, 2023106-2.75%10,021,957-3.36%761.22%6538.30%24-48.94%
Sep 30, 2023109-13.49%10,370,529-3.75%791.16%47-16.07%47-7.84%
Jun 30, 2023126-18.71%10,774,946-8.55%821.01%56-24.32%51-19.05%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv367.77K2.84%-
Vanguard Institutional Extnd Mkt Idx Tr150.92K1.16%-
Fidelity Small Cap Index107.48K0.83%5.54K
AQR Small Cap Multi-Style I96.26K0.74%9.72K
Invesco FTSE RAFI US 1500 Small-Mid ETF82.42K0.64%-39.00
Fidelity Extended Market Index60.61K0.47%3.30K
Schwab US Small-Cap ETF™50.79K0.39%-
Xtrackers Stoxx Global Div100 Swp ETF 1D48.80K0.38%48.80K
Vanguard Health Care ETF39.89K0.31%-39.00
RBC Microcap Value I36.90K0.28%9.00K

Recent Insider Transactions

DateNameRoleActivityValue
Nov 02, 2023Tarriff Scott CEOSell$148.33K
Nov 01, 2023Tarriff Scott CEOSell$150.98K
Oct 03, 2023Tarriff Scott CEOSell$144.45K
Oct 03, 2023Tarriff Scott CEOSell$10.73K
Oct 02, 2023Tarriff Scott CEOSell$144.85K

Insider Transactions Trends

DateBuySell
2024 Q1--
2023 Q4-5
2023 Q2-6
2023 Q1--
2022 Q4--

EGRX Ownership FAQ

Who Owns Eagle Pharmaceuticals?

Eagle Pharmaceuticals shareholders are primarily institutional investors at 75.40%, followed by 12.02% insiders and 12.58% retail investors. The average institutional ownership in Eagle Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.80%, which Eagle Pharmaceuticals exceeds.

Who owns the most shares of Eagle Pharmaceuticals?

Eagle Pharmaceuticals’s largest shareholders are Aigh capital management (1.21M shares, 9.25%), Citigroup (1M shares, 7.65%), and Nantahala capital management (1M shares, 7.64%). Together, they hold 24.54% of Eagle Pharmaceuticals’s total shares outstanding.

Does Blackrock own Eagle Pharmaceuticals?

Yes, BlackRock owns 2.69% of Eagle Pharmaceuticals, totaling 352.76K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.98M$. In the last quarter, BlackRock decreased its holdings by -545K shares, a -60.71% change.

Who is Eagle Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Aigh capital management is Eagle Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.11% of its assets in 1.21M Eagle Pharmaceuticals shares, valued at 6.78M$.

Who is the top mutual fund holder of Eagle Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Eagle Pharmaceuticals shares, with 2.84% of its total shares outstanding invested in 367.77K Eagle Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools